What Do Rare White Blood Cells Mean on a Lab Report?

A lab report noting “rare” white blood cells usually means a technician or automated analyzer spotted a small number of cells that do not normally circulate in the bloodstream. These might be immature cells released early from the bone marrow, unusually shaped mature cells, or cell types that typically stay confined to specific tissues. The finding can range from a harmless response to a viral infection all the way to an early signal of a blood cancer, so the meaning depends entirely on which type of cell was flagged and what else is happening in your blood work.

What “Rare” Means in Lab Language

When a lab report says “rare” next to a cell type, it is describing quantity on a rough scale. Most labs use a semi-quantitative grading system when a technician examines a blood smear under the microscope: none seen, rare, few, moderate, many. “Rare” generally means the technician had to search through many fields of view before spotting one or two of these cells. It sits at the low end of the scale, but its clinical importance has nothing to do with quantity alone. A single blast cell (an extremely immature white blood cell) in the peripheral blood is more alarming than a moderate number of reactive lymphocytes during a bout of the flu.

The peripheral blood film, where a thin smear of blood is examined under a microscope, remains one of the most valuable diagnostic tools in hematology despite decades of automation.¹ Automated analyzers do the initial counting and sorting, but when something looks unusual, a trained technician reviews the slide by eye. That manual review is where comments like “rare immature granulocytes” or “rare atypical lymphocytes” get added to your report.

Immature Granulocytes and the “Left Shift”

One of the most common findings is the presence of immature granulocytes, sometimes listed as bands, metamyelocytes, or myelocytes. These are white blood cells that have not finished maturing in the bone marrow but have been pushed into circulation early. In healthy adults (excluding newborns), you should rarely see these in peripheral blood. When they do show up, it signals that the bone marrow is ramping up production of infection-fighting cells, often in response to a bacterial infection or severe inflammation.²

Doctors sometimes call this a “left shift,” a term that dates back to the days when lab equipment plotted cell maturity on a graph with younger cells to the left. If your report mentions bands or immature granulocytes alongside an elevated total white blood cell count, your doctor is likely thinking about an acute infection, a post-surgical inflammatory response, or another cause of intense physiological stress. In a study of patients with systemic inflammation, band cells were present in the blood of about two-thirds of patients meeting criteria for an inflammatory response, compared to none in healthy subjects.³

The concern deepens when even more immature forms appear. If your report mentions myelocytes or promyelocytes, the bone marrow is under considerable pressure. This can still be from a severe infection, but it also raises the possibility of a myeloproliferative disorder like chronic myeloid leukemia, myelofibrosis, or myelodysplastic syndromes.² Among patients who died within a week of blood sampling during systemic inflammation, the levels of myelocytes and metamyelocytes were substantially higher than in those who survived longer.³ Context matters enormously here: the same cells in a hospitalized patient with a raging pneumonia mean something very different than in an outpatient who feels fine.

Toxic Changes in Neutrophils

Sometimes the unusual finding is not the type of cell but the way familiar cells look. Toxic granulation, Döhle bodies, and cytoplasmic vacuolization are all morphological changes seen in neutrophils (the most common white blood cell) under stress. Toxic granules are dark, coarse granules in the cytoplasm that appear when neutrophils mature abnormally fast, usually driven by the body’s production of granulocyte colony-stimulating factor (G-CSF) during an acute infection.⁴

In patients with sepsis, these toxic changes are dramatically more common. One observational study found toxic granules in about 56% of patients with sepsis compared to roughly 13% of those with a systemic inflammatory response from a non-infectious cause. Döhle bodies, pale blue inclusions within neutrophils, appeared only in the sepsis group and were completely absent in the non-sepsis group.⁵ Persistent or severe toxic granulation may indicate a poor prognosis, making it a useful early warning alongside other lab markers like C-reactive protein.⁴

If your lab report flags toxic changes but you are already being treated in a hospital for an infection, these findings are expected and help your medical team gauge severity. If they appear unexpectedly on outpatient blood work, they warrant prompt follow-up because they suggest your body is mounting a serious immune response to something.

Atypical Lymphocytes and Viral Infections

Atypical or reactive lymphocytes are another common “rare” finding. These are lymphocytes that have become activated and physically enlarged in response to a viral infection. The classic example is infectious mononucleosis caused by Epstein-Barr virus, where these swollen, oddly shaped lymphocytes can dominate the blood smear. They look so abnormal that they can occasionally be mistaken for cancerous cells.⁶

This is one of the least worrisome findings you can get. Atypical lymphocytes show up during many viral infections, including cytomegalovirus, hepatitis, and even some respiratory viruses. If your report says “rare atypical lymphocytes” and you have had a recent cold, flu-like illness, or feel generally run down, the finding is almost certainly reactive. It typically resolves on its own as the infection clears. The key distinction is between reactive lymphocytes, which are mature cells that have enlarged because they are actively fighting an infection, and true blast cells, which are immature cells that should never be in the bloodstream in significant numbers.

Blast Cells and the Leukemia Question

This is the finding that causes the most alarm. Blasts are the most immature precursor cells, and in healthy people they stay in the bone marrow. Finding even a small number of blasts in peripheral blood raises immediate concern about acute leukemia. In fact, acute leukemia can be diagnosed when blasts make up 30% or more of the cells in a blood sample, without even needing a bone marrow biopsy in some cases.⁷

When a report says “rare blasts,” the percentage is obviously well below that diagnostic threshold, but it still demands investigation. A few circulating blasts can appear during bone marrow recovery after chemotherapy or during severe infections, so they are not automatically a cancer diagnosis. However, your doctor will almost certainly order additional testing, which may include flow cytometry (a technique that identifies cells by their surface markers) and potentially a bone marrow biopsy to determine whether those blasts are reactive or malignant.

The emotional weight of seeing “blasts” on a lab report is enormous, and it is worth knowing that the word does not automatically mean leukemia. But it does always mean “this needs to be investigated further, soon.”

Plasma Cells in the Blood

Plasma cells are normally confined to the bone marrow and lymph tissue, where they produce antibodies. Finding them circulating in peripheral blood is unusual and gets flagged. A systematic literature review of cases involving reactive plasmacytosis found that infections, particularly viral infections, were the most common cause, accounting for roughly a third of all cases. The second most frequent cause was a type of lymphoma called angioimmunoblastic T-cell lymphoma, representing about a quarter of cases. Medications, other cancers, and autoimmune diseases accounted for the rest.⁸

The spread of possible causes here illustrates why a single line item on a lab report cannot give you a diagnosis. Circulating plasma cells might mean you recently fought off a virus and your immune system is still winding down, or they might be an early clue to a hematologic malignancy. The number of circulating plasma cells, the presence of other abnormalities on the blood smear, and your symptoms all guide what happens next.

Smudge Cells and Chronic Lymphocytic Leukemia

Smudge cells, sometimes called basket cells, are broken remnants of white blood cells that fall apart during slide preparation. They were first described in the late 1800s in patients with lymphocytic leukemia and were initially dismissed as an unimportant artifact.⁹ It turns out they are clinically meaningful. In chronic lymphocytic leukemia (CLL), the cancerous lymphocytes are particularly fragile, so they smudge easily when the blood is spread on a slide.

If your report mentions smudge cells and your lymphocyte count is elevated, your doctor may investigate for CLL. Interestingly, the percentage of smudge cells is not simply a function of how many lymphocytes you have or how the slide was prepared; it appears to reflect a property of the leukemia cells themselves and may carry prognostic information about how aggressively the disease behaves.⁹ Finding a few smudge cells on an otherwise normal blood count is less concerning, but it is still a detail your doctor should be aware of.

Oddly Shaped Neutrophils and Myelodysplasia

Sometimes the unusual feature is the shape of the cell’s nucleus rather than the cell type itself. One particularly telling abnormality is the pseudo-Pelger-Huët anomaly, where neutrophils have a bilobed or unsegmented nucleus instead of the normal multi-lobed shape. This change was detected in 92% of patients with myelodysplastic syndromes (MDS) in one study, and was also found in certain types of acute myeloid leukemia and chronic myeloid leukemia, but not in healthy subjects or patients with other blood disorders.¹⁰

MDS is a group of disorders in which the bone marrow produces blood cells that are abnormally shaped and do not function properly. It tends to affect older adults and can progress to acute leukemia. If your report mentions hypolobated neutrophils or the pseudo-Pelger-Huët anomaly, particularly in the context of low blood counts, your doctor will likely pursue further testing.¹¹

When Eosinophils or Basophils Look Wrong

Eosinophils and basophils are normally present in small numbers and rarely draw much attention on a routine blood count. But when these cells are elevated or morphologically abnormal, it can signal anything from allergies and parasitic infections to serious blood cancers.

Eosinophils with unusual granule patterns, particularly those containing basophilic (dark-staining) granules in otherwise mature cells, have been associated with a specific subtype of acute myeloid leukemia. However, research shows that morphological features of eosinophils alone have poor specificity for distinguishing between a reactive cause (like allergies or parasites) and a malignant one. Even experienced morphologists suspected a cancer diagnosis in about 39% of patients who turned out to have reactive eosinophilia.¹² Bone marrow examination is often needed to settle the question, particularly in cases of persistent high eosinophil counts.¹³

Basophils attract attention when they are markedly elevated, a condition called basophilia. This is uncommon in everyday lab work but is a recognized feature of chronic myeloid leukemia (CML), where basophil levels at diagnosis serve as a key prognostic factor. Basophils in CML produce inflammatory and growth-promoting molecules that can contribute to the spread of abnormal stem cells beyond the bone marrow.¹⁴

The Leukoerythroblastic Reaction

Occasionally a lab report will flag both immature white blood cells and immature red blood cells at the same time. This combination, called a leukoerythroblastic reaction, indicates that the bone marrow is under significant stress. The usual cast of characters includes metamyelocytes, myelocytes, promyelocytes, and sometimes blast cells on the white cell side, alongside nucleated red blood cells that normally remain in the marrow. In myelofibrotic disorders, teardrop-shaped red cells also appear.¹⁵

A leukoerythroblastic picture can arise from cancers that have spread to the bone marrow (metastatic infiltration), severe infections, or primary bone marrow disorders like myelofibrosis. The pattern is distinct enough that it usually triggers an urgent hematology workup. If your report describes this combination of findings, expect your medical team to move quickly toward imaging and a bone marrow biopsy.

Drug-Induced Changes That Mimic Disease

Not all unusual white blood cell findings point to infection or cancer. Certain medications, especially G-CSF (a drug given to boost white blood cell production after chemotherapy), can dramatically alter the blood picture. G-CSF administration has been reported to cause a transient flood of atypical monocytes that closely mimics acute myelomonocytic leukemia. In reported cases, patients on G-CSF developed white cell counts with up to 72% monocytes, a pattern that resolved completely once the drug was stopped.¹⁶

Toxic granulation in neutrophils, as mentioned earlier, can also result from G-CSF therapy rather than from infection.⁴ Corticosteroids, lithium, and certain immunosuppressants can all shift the types and proportions of white cells in ways that look abnormal on a report. This is one of the main reasons your doctor will ask about your medication list before interpreting an unusual blood count. A finding that looks ominous in isolation may be a predictable and harmless side effect of something you are taking.

How These Cells Get Flagged in the First Place

Modern hematology analyzers process hundreds of blood samples a day and are excellent at counting cells and sorting them into categories. But they have limitations. When the analyzer encounters a cell it cannot confidently classify, it generates a flag suggesting that a human look at the slide. Laboratories use review criteria to decide which flagged samples actually need manual inspection under a microscope and which can be released as is.

Emerging approaches combine traditional review criteria with machine learning models to improve the process, catching more genuinely abnormal samples while reducing the number of unnecessary manual reviews. One study found that adding a machine learning layer to existing criteria increased the sensitivity for detecting true abnormalities from about 57% to nearly 77%, while cutting the rate of unnecessary manual reviews compared to alternative criteria.¹⁷ In practical terms, this means labs are getting better at ensuring that genuinely abnormal cells get seen by a trained pair of eyes, even as the volume of blood work continues to grow.

For you as a patient, the takeaway is that a comment on your report about rare unusual cells almost always means a real human examined your blood under a microscope and decided the finding was worth documenting. It is not an automated glitch. But it is also not, by itself, a diagnosis. It is an observation that your doctor needs to interpret alongside your symptoms, your medical history, and often additional testing.

Why the Same Finding Can Mean Vastly Different Things

The recurring theme across all of these cell types is context-dependence. Rare immature granulocytes in a patient recovering from surgery are expected. The same cells in an otherwise healthy person at a routine checkup require explanation. Atypical lymphocytes during a mono infection are textbook. The same cells in someone with unexplained weight loss and night sweats deserve close scrutiny. Even experienced hematologists rely on the full clinical picture rather than isolated lab findings to guide their thinking.

If you see an unfamiliar cell type flagged on your lab report and your doctor has not called you about it, that usually means they have already reviewed it and placed it in context. If the finding triggers worry, the best approach is to ask your doctor specifically what type of unusual cell was seen, whether the rest of your blood count supports any concern, and whether follow-up testing is needed. A lab report is a snapshot, and “rare” unusual cells on a single snapshot often amount to background noise from a healthy immune system doing its job.

1
PubMed Central. Peripheral blood film – a review
2
Cytometry. Flow cytometric method for enumeration and classification of reactive immature granulocyte populations
3
PubMed Central. The diagnostic and prognostic significance of monitoring blood levels of immature neutrophils in patients with systemic inflammation
4
PubMed Central. Recognize the Significance of Detecting Toxic Granules in Sepsis
5
PubMed Central. Morphological changes in white blood cells in systemic inflammatory response syndrome (SIRS) with and without sepsis
6
PubMed Central. Immunophenotypic profile in acute infectious mononucleosis mimicking malignant lymphoproliferative disorder
7
PubMed. Use of peripheral blood blasts vs bone marrow blasts for diagnosis of acute leukemia
8
BMJ Journals. Systematic literature review of published cases of reactive plasmacytosis in peripheral blood and bone marrow
9
Mayo Clinic Proceedings. Using Smudge Cells on Routine Blood Smears to Predict Clinical Outcome in Chronic Lymphocytic Leukemia: A Universally Available Prognostic Test
10
PubMed. Diagnostic significance of detecting pseudo-Pelger-Huët anomalies and micro-megakaryocytes in myelodysplastic syndrome
11
PubMed. The pseudo-Pelger-Huët anomaly in pyoderma gangrenosum associated with myelodysplastic syndrome
12
PubMed Central. The role of eosinophil morphology in distinguishing between reactive eosinophilia and eosinophilia as a feature of a myeloid neoplasm
13
PubMed Central. Bone marrow morphology is a strong discriminator between chronic eosinophilic leukemia, not otherwise specified and reactive idiopathic hypereosinophilic syndrome
14
PubMed Central. The underestimated role of basophils in Ph+ chronic myeloid leukaemia
15
PubMed Central / Wiley Online Library. Systematic review about etiologic association to the leukoerythroblastic reaction
16
PubMed. Transient atypical monocytosis mimic acute myelomonocytic leukemia in post-chemotherapy patients receiving G-CSF
17
PubMed Central. Development of criteria to optimize manual smear review of automated complete blood counts using a machine learning model